BSF EnterpriseBSFAF Current Ratio is 1.69 as of Sep. 2025, which is 80% below its 10-year median of 8.30. The stock has 3 warning signs investors should review. Among 1,413 Biotechnology companies, BSF Enterprise ranks worse than 73.46% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. BSF Enterprise's current ratio for the quarter that ended in Sep. 2025 was 1.69.
BSF Enterprise has a current ratio of 1.69. It generally indicates good short-term financial strength.
The historical rank and industry rank for BSF Enterprise's Current Ratio or its related term are showing as below:
BSFAF'
s Current Ratio Range Over the Past 10 Years
Min: 1.7 Med: 8.3 Max: 15.77
Current: 1.7
During the past 7 years, BSF Enterprise's highest Current Ratio was 15.77. The lowest was 1.70. And the median was 8.30.
BSFAF's Current Ratio is ranked worse than 73.46% of 1413
companies
in the Biotechnology industry
Industry Median: 3.89
vs BSFAF: 1.70
BSF Enterprise (OTCPK:BSFAF) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
BSF Enterprise Current Ratio Related Terms
BSF Enterprise Current Ratio Historical Data
* Premium members only.
The historical data trend for BSF Enterprise's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSFAF vs VRTX, REGN, ALNY: Current Ratio Comparison
For the Biotechnology subindustry, BSF Enterprise's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BSF Enterprise Current Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BSF Enterprise's Current Ratio distribution charts can be found below:
* The bar in red indicates where BSF Enterprise's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSF Enterprise (BSFAF) has a Current Ratio of 1.69 as of Sep. 2025. This is 80% below median its historical median of 8.30. Over the past decade, BSF Enterprise's Current Ratio has ranged from 1.70 to 15.77. According to the industry distribution chart, BSF Enterprise ranks #1038 out of 1413 companies in the Biotechnology industry, placing it in the top 73.5%.
Is BSF Enterprise's Current Ratio too high?
BSF Enterprise's current Current Ratio of 1.69 is 80% below median its 10-year median of 8.30. Over the past 10 years, this metric has ranged from a low of 1.70 to a high of 15.77. The Biotechnology industry median Current Ratio is 3.89. BSF Enterprise's value of 1.69 is 56.6% below this industry median. Based on the distribution chart, BSF Enterprise ranks #1038 out of 1413 companies in the Biotechnology industry, which is below the industry midpoint.
How does BSF Enterprise's Current Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BSF Enterprise ranks #1038 out of 1413 companies for Current Ratio. This places BSF Enterprise in the lower half of its industry. The industry median Current Ratio is 3.89. BSF Enterprise's value of 1.69 is 56.6% below this benchmark. Historically, BSF Enterprise's own Current Ratio has ranged from 1.70 to 15.77 over the past decade. While the company's 10-year median is 8.30 vs. the industry median of 3.89, BSF Enterprise has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Biotechnology company?
The median Current Ratio among Biotechnology companies is 3.89, based on 1,413 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BSF Enterprise's current Current Ratio of 1.69 is 56.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median Current Ratio is 3.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BSF Enterprise's current Current Ratio is 1.69, which is 80% below median its own 10-year median of 8.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BSF Enterprise stock overvalued right now?
BSF Enterprise (BSFAF) has a current Current Ratio of 1.69. The current Current Ratio is 1.69, which is 80% below median its 10-year median of 8.30 and 56.6% below the Biotechnology industry median of 3.89. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For BSF Enterprise (BSFAF), the current Current Ratio is 1.69 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BSF Enterprise PLC is a United Kingdom-based biotech company. The Company is focused on developing biotechnological solutions using cell-based tissue engineering to help generate cultured meat, lab-grown leather, as well as human corneas, collagen growth and skin substitutes. The Company operates through its wholly owned subsidiary, 3D Bio-Tissues Limited (3DBT), which is a clinical and cellular agriculture company engaged in producing human corneas that could help restore vision to millions of people.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSFAF has been successfully added to your 